TY - JOUR
T1 - Associations of combined genetic and lifestyle risks with hypertension and home hypertension
AU - the ToMMo investigators
AU - Takase, Masato
AU - Hirata, Takumi
AU - Nakaya, Naoki
AU - Nakamura, Tomohiro
AU - Kogure, Mana
AU - Hatanaka, Rieko
AU - Nakaya, Kumi
AU - Chiba, Ippei
AU - Kanno, Ikumi
AU - Nochioka, Kotaro
AU - Tsuchiya, Naho
AU - Narita, Akira
AU - Metoki, Hirohito
AU - Satoh, Michihiro
AU - Obara, Taku
AU - Ishikuro, Mami
AU - Ohseto, Hisashi
AU - Uruno, Akira
AU - Kobayashi, Tomoko
AU - Kodama, Eiichi N.
AU - Hamanaka, Yohei
AU - Orui, Masatsugu
AU - Ogishima, Soichi
AU - Nagaie, Satoshi
AU - Fuse, Nobuo
AU - Sugawara, Junichi
AU - Kuriyama, Shinichi
AU - Tamiya, Gen
AU - Hozawa, Atsushi
AU - Yamamoto, Masayuki
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/8
Y1 - 2024/8
N2 - No study, to our knowledge, has constructed a polygenic risk score based on clinical blood pressure and investigated the association of genetic and lifestyle risks with home hypertension. We examined the associations of combined genetic and lifestyle risks with hypertension and home hypertension. In a cross-sectional study of 7027 Japanese individuals aged ≥20 years, we developed a lifestyle score based on body mass index, alcohol consumption, physical activity, and sodium-to-potassium ratio, categorized into ideal, intermediate, and poor lifestyles. A polygenic risk score was constructed with the target data (n = 1405) using publicly available genome-wide association study summary statistics from BioBank Japan. Using the test data (n = 5622), we evaluated polygenic risk score performance and examined the associations of combined genetic and lifestyle risks with hypertension and home hypertension. Hypertension and home hypertension were defined as blood pressure measured at a community-support center ≥140/90 mmHg or at home ≥135/85 mmHg, respectively, or self-reported treatment for hypertension. In the test data, 2294 and 2322 participants had hypertension and home hypertension, respectively. Both polygenic risk and lifestyle scores were independently associated with hypertension and home hypertension. Compared with those of participants with low genetic risk and an ideal lifestyle, the odds ratios for hypertension and home hypertension in the low genetic risk and poor lifestyle group were 1.94 (95% confidence interval, 1.34–2.80) and 2.15 (1.60–2.90), respectively. In summary, lifestyle is important to prevent hypertension; nevertheless, participants with high genetic risk should carefully monitor their blood pressure despite a healthy lifestyle. (Figure presented.)
AB - No study, to our knowledge, has constructed a polygenic risk score based on clinical blood pressure and investigated the association of genetic and lifestyle risks with home hypertension. We examined the associations of combined genetic and lifestyle risks with hypertension and home hypertension. In a cross-sectional study of 7027 Japanese individuals aged ≥20 years, we developed a lifestyle score based on body mass index, alcohol consumption, physical activity, and sodium-to-potassium ratio, categorized into ideal, intermediate, and poor lifestyles. A polygenic risk score was constructed with the target data (n = 1405) using publicly available genome-wide association study summary statistics from BioBank Japan. Using the test data (n = 5622), we evaluated polygenic risk score performance and examined the associations of combined genetic and lifestyle risks with hypertension and home hypertension. Hypertension and home hypertension were defined as blood pressure measured at a community-support center ≥140/90 mmHg or at home ≥135/85 mmHg, respectively, or self-reported treatment for hypertension. In the test data, 2294 and 2322 participants had hypertension and home hypertension, respectively. Both polygenic risk and lifestyle scores were independently associated with hypertension and home hypertension. Compared with those of participants with low genetic risk and an ideal lifestyle, the odds ratios for hypertension and home hypertension in the low genetic risk and poor lifestyle group were 1.94 (95% confidence interval, 1.34–2.80) and 2.15 (1.60–2.90), respectively. In summary, lifestyle is important to prevent hypertension; nevertheless, participants with high genetic risk should carefully monitor their blood pressure despite a healthy lifestyle. (Figure presented.)
KW - Hypertension
KW - Lifestyle risk reduction
KW - Polygenic risk score
UR - http://www.scopus.com/inward/record.url?scp=85196912919&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85196912919&partnerID=8YFLogxK
U2 - 10.1038/s41440-024-01705-8
DO - 10.1038/s41440-024-01705-8
M3 - Article
C2 - 38914703
AN - SCOPUS:85196912919
SN - 0916-9636
VL - 47
SP - 2064
EP - 2074
JO - Hypertension Research
JF - Hypertension Research
IS - 8
ER -